CRISPR Therapeutics AG — All Filings
828 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-122274 | Mar 24, 2026 | Mar 20, 2026 |
| 4 | 4 | 0001193125-26-122272 | Mar 24, 2026 | Mar 20, 2026 |
| 4 | 4 | 0001193125-26-122268 | Mar 24, 2026 | Mar 20, 2026 |
| 4 | 4 | 0001193125-26-122267 | Mar 24, 2026 | Mar 20, 2026 |
| 4 | 4 | 0001193125-26-111286 | Mar 17, 2026 | Mar 14, 2026 |
| 4 | 4 | 0001193125-26-111284 | Mar 17, 2026 | Mar 14, 2026 |
| 4 | 4 | 0001193125-26-111281 | Mar 17, 2026 | Mar 14, 2026 |
| 4 | 4 | 0001193125-26-111278 | Mar 17, 2026 | Mar 14, 2026 |
| 8-K | 8-K | 0001193125-26-108333 | Mar 16, 2026 | — |
| 4 | 4 | 0001193125-26-104481 | Mar 12, 2026 | Mar 10, 2026 |
| 4 | 4 | 0001193125-26-104480 | Mar 12, 2026 | Mar 10, 2026 |
| 8-K | 8-K | 0001193125-26-101073 | Mar 11, 2026 | Mar 10, 2026 |
| 4 | 4 | 0001193125-26-061712 | Feb 20, 2026 | Feb 18, 2026 |
| 4 | 4 | 0001193125-26-061710 | Feb 20, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | — | 0000940594-26-000006 | Feb 17, 2026 | — |
| 10-K | 10-K | 0001193125-26-048957 | Feb 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-048873 | Feb 12, 2026 | — |
| SCHEDULE 13G/A | — | 0001562230-26-000001 | Feb 5, 2026 | — |
| 4 | 4 | 0001193125-26-024955 | Jan 27, 2026 | Apr 3, 2025 |
| 4 | 4 | 0001193125-26-022845 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | 4 | 0001193125-26-019733 | Jan 22, 2026 | Jan 20, 2026 |
| 144 | — | 0001958244-26-000050 | Jan 22, 2026 | — |
| 144 | — | 0001950047-26-000625 | Jan 22, 2026 | — |
| 144 | — | 0001958244-26-000046 | Jan 20, 2026 | — |
| 8-K | 8-K | 0001193125-26-009880 | Jan 12, 2026 | — |
| 4 | 4 | 0001193125-26-007875 | Jan 8, 2026 | Jan 6, 2026 |
| 144 | — | 0001950047-26-000216 | Jan 6, 2026 | — |
| 4 | 4 | 0001193125-25-331162 | Dec 23, 2025 | Dec 22, 2025 |
| 4 | 4 | 0001193125-25-329010 | Dec 22, 2025 | Dec 18, 2025 |
| 144 | — | 0001950047-25-010601 | Dec 22, 2025 | — |
| SCHEDULE 13G | — | 0000940594-25-000008 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-273337 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-273329 | Nov 10, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-106355 | Nov 4, 2025 | — |
| 4 | 4 | 0001193125-25-243819 | Oct 20, 2025 | Oct 16, 2025 |
| 4 | 4 | 0001193125-25-240438 | Oct 15, 2025 | Oct 13, 2025 |
| 4 | 4 | 0001193125-25-240437 | Oct 15, 2025 | Oct 13, 2025 |
| 8-K | 8-K | 0001193125-25-240282 | Oct 15, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-240259 | Oct 15, 2025 | — |
| 4 | 4 | 0001193125-25-230511 | Oct 3, 2025 | — |
| 4 | 4 | 0001193125-25-230508 | Oct 3, 2025 | — |
| 4 | 4 | 0001193125-25-230506 | Oct 3, 2025 | — |
| 4 | 4 | 0001193125-25-230505 | Oct 3, 2025 | — |
| 4 | 4 | 0001193125-25-209353 | Sep 19, 2025 | Sep 17, 2025 |
| 4 | 4 | 0001682019-25-000003 | Aug 19, 2025 | Aug 16, 2025 |
| 4 | 4 | 0001688192-25-000004 | Aug 8, 2025 | Aug 6, 2025 |
| 10-Q | 10-Q | 0000950170-25-102052 | Aug 4, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-102027 | Aug 4, 2025 | — |
| 4 | 4 | 0000950170-25-096666 | Jul 17, 2025 | Jul 16, 2025 |
| SCHEDULE 13G | — | 0002052113-25-002963 | Jul 17, 2025 | — |